Analysts have recently evaluated WAVE Life Sciences and provided 12-month price targets. The average target is $16.0, ...

BACKGROUND--Previous estimates of the survival times of patients with alpha 1-antitrypsin deficiency have been based on selected patients. METHODS--The survival times of 397 patients with severe alpha ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD).

A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...

A high-level overview of Alibaba Group Holding Limited (BABA) stock. View (BABA) real-time stock price, chart, news, analysis, analyst reviews and more.

Opus Genetics GAAP EPS of -$0.24 misses by $0.04, revenue of $4.37M beats by $1.12M SA News Thu, May 15 Opus Genetics, Inc. SEC Filing - Annual Report (10-K) March 31, 2025 ...

Alfie Clamp, a British toddler has an extra strand of DNA that has baffled doctors who have been confronted with this extremely rare genetic disorder for the first time.

“While genetics studies have identified mutations in some human genes that increase the risk of developing type 1 diabetes, genetics alone cannot fully explain the increasing incidence rates in the ...